- Home
- NVCT vs TPVG Comparison
NVCT vs TPVG Comparison
Compare NVCT & TPVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVCT | TPVG |
|---|---|---|
| Founded | 2020 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 220.0M | 182.2M |
| IPO Year | 2021 | 2013 |
Fundamental Metrics
Financial Performance| Metric | NVCT | TPVG |
|---|---|---|
| Price | $7.49 | $5.06 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 5 |
| Target Price | ★ $13.50 | $6.00 |
| AVG Volume (30 Days) | 52.1K | ★ 629.1K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 18.07% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.05 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.67 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $4.85 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.55 | $4.48 |
| 52 Week High | $11.52 | $7.53 |
Technical Indicators
Market Signals| Indicator | NVCT | TPVG |
|---|---|---|
| Relative Strength Index (RSI) | 34.64 | 49.72 |
| Support Level | $7.23 | N/A |
| Resistance Level | $8.46 | $5.50 |
| Average True Range (ATR) | 0.40 | 0.23 |
| MACD | -0.10 | 0.04 |
| Stochastic Oscillator | 18.35 | 67.03 |
Price Performance
Historical ComparisonAbout NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About TPVG TriplePoint Venture Growth BDC Corp.
TriplePoint Venture Growth BDC Corp is a closed-end, non-diversified management investment company. Its investment objective is to maximize its total return to stockholders in the form of current income and, to a lesser extent, capital appreciation. The fund focuses on companies operating in the fields of biofuels, business applications software, wireless communications equipment, e-commerce, clothing and accessories, conferencing equipment and services, personal goods, financial institutions and services, entertainment, mixed retailing, and healthcare services. Geographically, all the firm's operations are located across the United States.